Urethral discharge in men

Chlamydia trachomatis - 40% of cases of NGU

Mycoplasma genitalium – > 20% of symptomatic urethritis

Ureaplasma urealyticum – role unclear. Biovar 2 may account for 5-10% NSU

Trichomonas vaginalis

Herpes simplex virus

Adenovirus

Others: Epstein Barr Virus, N.Meningitidis, Haemophilus sp, Candida sp, foreign bodies, urethral stricture, non infective (idiopathic/possibly inflammatory)

Symptoms

• Urethral discharge
• Dysuria
• Urethral irritation
• Fever, painful lymph nodes and / or haematuria if HSV causative agent
• Nil

Signs

• Urethral discharge
• Tender inguinal lymphadenopathy if HSV causative agent
• Nil

Complications (occurring in <1%)

Epididymo-orchitis
Sexually acquired reactive arthritis (SARA)

Confirmed by demonstration of PMNLs in the anterior urethra.

1. Gram stained urethral smear

Technique: insert a plastic inoculation loop at least 1 cm into urethra and withdraw, gently scraping the walls of the urethra, spread thinly on a dry slide for microscopy.

Definition: 5 or more PMNL per high-powered field averaged over 5 fields.
Ideally the slide should be made >2 hours since last passing urine. In symptomatic patients who have recently voided/who have normal microscopy consider early morning smear (EMS) – arrange to return first thing having held urine overnight.

2. Gram stained “threads” from a first pass urine (FPU)

sample if no material gained from urethral smear and threads visible.
>10 PMNL per HPF in at least 5 fields.

If > 4 PMNL per high-powered field and Gram-negative intracellular diplococci (GNDC) are seen – a presumptive diagnosis of Gonococcal urethritis is made.

If > 4PMNL per high-powered field are seen with no GNDC(standard is to review 20 fields to confirm no GNID) a diagnosis of NGU is made.

Further Investigations

• First pass urine (FPU) for CT/GC NAAT.
• We do not do routine testing for M. Genitalium at present but this can be considered in cases of persistent urethritis (discuss with senior GUM cover).
• GC cultures if diagnosis suggestive of possible GC urethritis (profuse purulent discharge, microscopy with paired cocci suggestive of possible NG, contact of GC). The general rule is to
  do cultures if treatment for gonorrhoea is considered – see Gonorrhoea protocol for correct plating technique.

Additional investigations to consider:

• If symptoms suggestive of UTI send mid stream urine (MSU).
• If symptoms suggestive of HSV infection consider urethral swab sent in red-topped universal transport medium (UTM) for HSV PCR.

Patients seen at local clinics with symptoms or signs suggestive of urethritis should be referred to Galashiels for microscopy (and GC culture if needed). When patients decline or are unable to attend, the diagnosis can be made on the following basis:

• Presence of mucopurulent discharge on examination.
• Urinalysis of FPU: Leucocytes + or more.

Management – see NGU treatment flowchart.

Non-gonococcal urethritis

Gonococcal urethritis 

See GUM protocol Section 2 for management and PN.

Non-gonococcal urethritis: additional management points

Sexual contacts

1. Partner notification should be discussed with all patients.
2. If CT or GC are detected follow guidance for sexual contacts on relevant protocol
3. All partners in the preceding 4 weeks should be advised to attend for STI screening and treatment consideration(with same regime as index patient – unless recurrent/persistent NGU and suspected genitalium)

Patient information

1. An explanation of the cases of urethritis including non-infective causes.
2. Explanation of potential short- and long-term complications.
3. Avoidance of sexual contact until both partners treated and for 2 weeks after the start of antibiotics - this is likely to reduce the risk of selecting/inducing macrolide resistance if exposed to M.genitalium or Neisseria gonorrhoeae which would make these infections more difficult to treat.
4. Provide link to written information – patient info leaflet.

Follow up

No follow up is necessary.

Persistent/recurrent NGU

• Persistent NGU – when symptoms do not resolve following treatment and ongoing urethritis is confirmed microscopically. There is no specific guidance on the point at which symptoms  are regarded as persistent.  Patients should be asymptomatic at 2 weeks after start of treatment, although mild symptoms may continue for longer and are commonly experienced in the absence of any persisting microscopic evidence of NGU.
• Recurrent NGU - recurrent symptomatic microscopically confirmed urethritis occurring up to 90 days following treatment of acute NGU
• Only diagnosed in the presence of >4 PMNL per HPF (min 5 fields) on gram stained urethral smear
• Remember:
  • Confirm adherence to previous treatment
  • Confirm any regular partners have been treated
  • Exclude re-infection

If diagnosis confirmed microscopically

Send sample for Mycoplasma genitalium  - refer to Mycoplasma Genitalium Protocol – GUM protocol .

Management of confirmed persistent/recurrent NGU - see NGU treatment flowchart

If empirical treatment appropriate – eg severe symptoms, likely to have sexual contact

1.  If patient has completed 1 week of doxycycline within last 2 weeks:

 Azithromycin  1g D1/500mg D2/500mg D3

+/- Metronidazole 400mg BD for 5 days

Consider treating regular partners with same antibiotics.

Await M.genitalium result

2.  If patient has not completed 1 week of doxycycline within 2 weeks:

Doxycycline 100mg BD for 7 days

Await M.genitalium result

If appropriate to wait for M.genitalium result – eg. mild symptoms, unlikely to have sexual contact

If M.genitalium Positive – follow M.genitalium protocol

If M.genitalium negative
Treat with azithromycin 1g D1/500mg D2/500mgD3
PLUS metronidazole 400mg BD for 5 days.

Ongoing symptoms but non-diagnostic urethral smear

Some patients complain of ongoing symptoms but urethral smear is not indicative of ongoing infection. In these cases:

• Ensure MSU sent and negative
• Firm reassurance that no evidence of infection or inflammation
• Discourage repeated self-examination
• Consider chronic pelvic pain
• Consider Urology referral.